Bruck Kifle

Array ( [id] => 9227566 [patent_doc_number] => 08633234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Rifaximin' [patent_app_type] => utility [patent_app_number] => 12/441368 [patent_app_country] => US [patent_app_date] => 2007-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3604 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12441368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13878 [patent_doc_number] => 07803793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Heterocyclic derived metalloprotease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/858972 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37568 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803793.pdf [firstpage_image] =>[orig_patent_app_number] => 11858972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509351 [patent_doc_number] => 20090082558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Amorphous form of rifaximin and processes for its preparation' [patent_app_type] => utility [patent_app_number] => 11/902211 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1843 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082558.pdf [firstpage_image] =>[orig_patent_app_number] => 11902211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322649 [patent_doc_number] => 07517882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/856476 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5587 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517882.pdf [firstpage_image] =>[orig_patent_app_number] => 11856476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813776 [patent_doc_number] => 07414049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => '4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives' [patent_app_type] => utility [patent_app_number] => 11/855262 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15570 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414049.pdf [firstpage_image] =>[orig_patent_app_number] => 11855262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636875 [patent_doc_number] => 20100035863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => '2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 12/440899 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70691 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035863.pdf [firstpage_image] =>[orig_patent_app_number] => 12440899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316479 [patent_doc_number] => 20090281077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Cyclic sulfones useful as mitochondrial sodium-calcium exchangers' [patent_app_type] => utility [patent_app_number] => 12/440440 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2206 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281077.pdf [firstpage_image] =>[orig_patent_app_number] => 12440440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222765 [patent_doc_number] => 20100056496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'MUSCARINIC RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/439771 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14209 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056496.pdf [firstpage_image] =>[orig_patent_app_number] => 12439771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772854 [patent_doc_number] => 20080058513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'System and process for purifying an aqueous solution of crude caprolactam' [patent_app_type] => utility [patent_app_number] => 11/897883 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3848 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058513.pdf [firstpage_image] =>[orig_patent_app_number] => 11897883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939433 [patent_doc_number] => 20080076752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Novel Lactams And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/844451 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85571 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076752.pdf [firstpage_image] =>[orig_patent_app_number] => 11844451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496392 [patent_doc_number] => 20090264420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'ORGANIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/438811 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25844 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264420.pdf [firstpage_image] =>[orig_patent_app_number] => 12438811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813915 [patent_doc_number] => 20080194546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/842927 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94563 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194546.pdf [firstpage_image] =>[orig_patent_app_number] => 11842927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840566 [patent_doc_number] => 07390896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Cyclic malonamides as inhibitors of Aβ protein production' [patent_app_type] => utility [patent_app_number] => 11/841081 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42805 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390896.pdf [firstpage_image] =>[orig_patent_app_number] => 11841081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211568 [patent_doc_number] => 07622474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Platelet ADP receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 11/841711 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22540 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622474.pdf [firstpage_image] =>[orig_patent_app_number] => 11841711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603616 [patent_doc_number] => 20100063021 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-03-11 [patent_title] => 'Modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 11/894092 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16649 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0063/20100063021.pdf [firstpage_image] =>[orig_patent_app_number] => 11894092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603616 [patent_doc_number] => 20100063021 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-03-11 [patent_title] => 'Modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 11/894092 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16649 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0063/20100063021.pdf [firstpage_image] =>[orig_patent_app_number] => 11894092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670645 [patent_doc_number] => 20080045705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => ' Production Method' [patent_app_type] => utility [patent_app_number] => 11/840397 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5049 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045705.pdf [firstpage_image] =>[orig_patent_app_number] => 11840397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4933489 [patent_doc_number] => 20080004264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Rapamycin analogues and the uses thereof in the treatment of neurological disorders' [patent_app_type] => utility [patent_app_number] => 11/893090 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004264.pdf [firstpage_image] =>[orig_patent_app_number] => 11893090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658227 [patent_doc_number] => 20080027089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Rapamycin derivatives and the uses thereof in the treatment of neurological disorders' [patent_app_type] => utility [patent_app_number] => 11/891879 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6264 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027089.pdf [firstpage_image] =>[orig_patent_app_number] => 11891879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221069 [patent_doc_number] => 07608615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/893380 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5340 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608615.pdf [firstpage_image] =>[orig_patent_app_number] => 11893380 [rel_patent_id] =>[rel_patent_doc_number] =>)